Trial intelligence / Profile preview

Microbubble sentinel node detection in vulvar cancer

2012-000988-25Phase 4Unknown

Sponsor
Gateshead Health NHS Foundation Trust
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sulfur hexafluoride in Vulval carcinoma, sponsored by Gateshead Health NHS Foundation Trust. Primary endpoint: Recruitment feasibility. Status: unknown.

02

Drugs

sulfur hexafluoride
03

Conditions

Vulval carcinoma

Beyond the preview

Go deeper on 2012-000988-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000988-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call